Global Covid-19 Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 134
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Covid-19 Treatment market size was valued at USD 14310 million in 2023 and is forecast to a readjusted size of USD 41 million by 2030 with a CAGR of -56.8% during review period.
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
The Global Info Research report includes an overview of the development of the Covid-19 Treatment industry chain, the market status of Children (Life Support, Antiviral Medicine), Adult (Life Support, Antiviral Medicine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Covid-19 Treatment.
Regionally, the report analyzes the Covid-19 Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Covid-19 Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Covid-19 Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Covid-19 Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Life Support, Antiviral Medicine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Covid-19 Treatment market.
Regional Analysis: The report involves examining the Covid-19 Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Covid-19 Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Covid-19 Treatment:
Company Analysis: Report covers individual Covid-19 Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Covid-19 Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Children, Adult).
Technology Analysis: Report covers specific technologies relevant to Covid-19 Treatment. It assesses the current state, advancements, and potential future developments in Covid-19 Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Covid-19 Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Covid-19 Treatment market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.
Market segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Market segment by End User
Children
Adult
Market segment by players, this report covers
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Treatment, with revenue, gross margin and global market share of Covid-19 Treatment from 2019 to 2024.
Chapter 3, the Covid-19 Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Covid-19 Treatment market forecast, by regions, type and end user, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Treatment.
Chapter 13, to describe Covid-19 Treatment research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Covid-19 Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Covid-19 Treatment by Type
1.3.1 Overview: Global Covid-19 Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Covid-19 Treatment Consumption Value Market Share by Type in 2023
1.3.3 Life Support
1.3.4 Antiviral Medicine
1.3.5 Antibody Treatments
1.3.6 Others
1.4 Global Covid-19 Treatment Market by End User
1.4.1 Overview: Global Covid-19 Treatment Market Size by End User: 2019 Versus 2023 Versus 2030
1.4.2 Children
1.4.3 Adult
1.5 Global Covid-19 Treatment Market Size & Forecast
1.6 Global Covid-19 Treatment Market Size and Forecast by Region
1.6.1 Global Covid-19 Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Covid-19 Treatment Market Size by Region, (2019-2030)
1.6.3 North America Covid-19 Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe Covid-19 Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Covid-19 Treatment Market Size and Prospect (2019-2030)
1.6.6 South America Covid-19 Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Covid-19 Treatment Market Size and Prospect (2019-2030)
2.1 Cadila Healthcare
2.1.1 Cadila Healthcare Details
2.1.2 Cadila Healthcare Major Business
2.1.3 Cadila Healthcare Covid-19 Treatment Product and Solutions
2.1.4 Cadila Healthcare Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Cadila Healthcare Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Covid-19 Treatment Product and Solutions
2.2.4 Johnson & Johnson Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 ImmunoPrecise
2.3.1 ImmunoPrecise Details
2.3.2 ImmunoPrecise Major Business
2.3.3 ImmunoPrecise Covid-19 Treatment Product and Solutions
2.3.4 ImmunoPrecise Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ImmunoPrecise Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Covid-19 Treatment Product and Solutions
2.4.4 Novartis Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Covid-19 Treatment Product and Solutions
2.5.4 AstraZeneca Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Covid-19 Treatment Product and Solutions
2.6.4 Cipla Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cipla Recent Developments and Future Plans
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Covid-19 Treatment Product and Solutions
2.7.4 AbbVie Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AbbVie Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Covid-19 Treatment Product and Solutions
2.8.4 Bayer Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Regeneron Pharmaceuticals
2.9.1 Regeneron Pharmaceuticals Details
2.9.2 Regeneron Pharmaceuticals Major Business
2.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
2.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.10 Ascletis Pharma
2.10.1 Ascletis Pharma Details
2.10.2 Ascletis Pharma Major Business
2.10.3 Ascletis Pharma Covid-19 Treatment Product and Solutions
2.10.4 Ascletis Pharma Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Ascletis Pharma Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Covid-19 Treatment Product and Solutions
2.11.4 GlaxoSmithKline Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Gilead Sciences
2.12.1 Gilead Sciences Details
2.12.2 Gilead Sciences Major Business
2.12.3 Gilead Sciences Covid-19 Treatment Product and Solutions
2.12.4 Gilead Sciences Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Gilead Sciences Recent Developments and Future Plans
2.13 Pharmstandard
2.13.1 Pharmstandard Details
2.13.2 Pharmstandard Major Business
2.13.3 Pharmstandard Covid-19 Treatment Product and Solutions
2.13.4 Pharmstandard Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pharmstandard Recent Developments and Future Plans
2.14 Fujifilm Holdings
2.14.1 Fujifilm Holdings Details
2.14.2 Fujifilm Holdings Major Business
2.14.3 Fujifilm Holdings Covid-19 Treatment Product and Solutions
2.14.4 Fujifilm Holdings Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Fujifilm Holdings Recent Developments and Future Plans
2.15 Zhejiang Hisun Pharmaceutical Co. Ltd
2.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Details
2.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
2.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
2.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
2.16 Roche
2.16.1 Roche Details
2.16.2 Roche Major Business
2.16.3 Roche Covid-19 Treatment Product and Solutions
2.16.4 Roche Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Roche Recent Developments and Future Plans
2.17 Sanofi
2.17.1 Sanofi Details
2.17.2 Sanofi Major Business
2.17.3 Sanofi Covid-19 Treatment Product and Solutions
2.17.4 Sanofi Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sanofi Recent Developments and Future Plans
2.18 Pfizer
2.18.1 Pfizer Details
2.18.2 Pfizer Major Business
2.18.3 Pfizer Covid-19 Treatment Product and Solutions
2.18.4 Pfizer Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Pfizer Recent Developments and Future Plans
2.19 Eli Lilly
2.19.1 Eli Lilly Details
2.19.2 Eli Lilly Major Business
2.19.3 Eli Lilly Covid-19 Treatment Product and Solutions
2.19.4 Eli Lilly Covid-19 Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Eli Lilly Recent Developments and Future Plans
3.1 Global Covid-19 Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Covid-19 Treatment by Company Revenue
3.2.2 Top 3 Covid-19 Treatment Players Market Share in 2023
3.2.3 Top 6 Covid-19 Treatment Players Market Share in 2023
3.3 Covid-19 Treatment Market: Overall Company Footprint Analysis
3.3.1 Covid-19 Treatment Market: Region Footprint
3.3.2 Covid-19 Treatment Market: Company Product Type Footprint
3.3.3 Covid-19 Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Covid-19 Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Covid-19 Treatment Market Forecast by Type (2025-2030)
5.1 Global Covid-19 Treatment Consumption Value Market Share by End User (2019-2024)
5.2 Global Covid-19 Treatment Market Forecast by End User (2025-2030)
6.1 North America Covid-19 Treatment Consumption Value by Type (2019-2030)
6.2 North America Covid-19 Treatment Consumption Value by End User (2019-2030)
6.3 North America Covid-19 Treatment Market Size by Country
6.3.1 North America Covid-19 Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Covid-19 Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada Covid-19 Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico Covid-19 Treatment Market Size and Forecast (2019-2030)
7.1 Europe Covid-19 Treatment Consumption Value by Type (2019-2030)
7.2 Europe Covid-19 Treatment Consumption Value by End User (2019-2030)
7.3 Europe Covid-19 Treatment Market Size by Country
7.3.1 Europe Covid-19 Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Covid-19 Treatment Market Size and Forecast (2019-2030)
7.3.3 France Covid-19 Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Covid-19 Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia Covid-19 Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy Covid-19 Treatment Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Covid-19 Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Covid-19 Treatment Consumption Value by End User (2019-2030)
8.3 Asia-Pacific Covid-19 Treatment Market Size by Region
8.3.1 Asia-Pacific Covid-19 Treatment Consumption Value by Region (2019-2030)
8.3.2 China Covid-19 Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan Covid-19 Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea Covid-19 Treatment Market Size and Forecast (2019-2030)
8.3.5 India Covid-19 Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Covid-19 Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia Covid-19 Treatment Market Size and Forecast (2019-2030)
9.1 South America Covid-19 Treatment Consumption Value by Type (2019-2030)
9.2 South America Covid-19 Treatment Consumption Value by End User (2019-2030)
9.3 South America Covid-19 Treatment Market Size by Country
9.3.1 South America Covid-19 Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Covid-19 Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina Covid-19 Treatment Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Covid-19 Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Covid-19 Treatment Consumption Value by End User (2019-2030)
10.3 Middle East & Africa Covid-19 Treatment Market Size by Country
10.3.1 Middle East & Africa Covid-19 Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Covid-19 Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Covid-19 Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE Covid-19 Treatment Market Size and Forecast (2019-2030)
11.1 Covid-19 Treatment Market Drivers
11.2 Covid-19 Treatment Market Restraints
11.3 Covid-19 Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Covid-19 Treatment Industry Chain
12.2 Covid-19 Treatment Upstream Analysis
12.3 Covid-19 Treatment Midstream Analysis
12.4 Covid-19 Treatment Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Covid-19 Treatment Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Global Covid-19 Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Covid-19 Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Cadila Healthcare Company Information, Head Office, and Major Competitors
Table 6. Cadila Healthcare Major Business
Table 7. Cadila Healthcare Covid-19 Treatment Product and Solutions
Table 8. Cadila Healthcare Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Cadila Healthcare Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Covid-19 Treatment Product and Solutions
Table 13. Johnson & Johnson Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. ImmunoPrecise Company Information, Head Office, and Major Competitors
Table 16. ImmunoPrecise Major Business
Table 17. ImmunoPrecise Covid-19 Treatment Product and Solutions
Table 18. ImmunoPrecise Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. ImmunoPrecise Recent Developments and Future Plans
Table 20. Novartis Company Information, Head Office, and Major Competitors
Table 21. Novartis Major Business
Table 22. Novartis Covid-19 Treatment Product and Solutions
Table 23. Novartis Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis Recent Developments and Future Plans
Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Covid-19 Treatment Product and Solutions
Table 28. AstraZeneca Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. AstraZeneca Recent Developments and Future Plans
Table 30. Cipla Company Information, Head Office, and Major Competitors
Table 31. Cipla Major Business
Table 32. Cipla Covid-19 Treatment Product and Solutions
Table 33. Cipla Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Cipla Recent Developments and Future Plans
Table 35. AbbVie Company Information, Head Office, and Major Competitors
Table 36. AbbVie Major Business
Table 37. AbbVie Covid-19 Treatment Product and Solutions
Table 38. AbbVie Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. AbbVie Recent Developments and Future Plans
Table 40. Bayer Company Information, Head Office, and Major Competitors
Table 41. Bayer Major Business
Table 42. Bayer Covid-19 Treatment Product and Solutions
Table 43. Bayer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bayer Recent Developments and Future Plans
Table 45. Regeneron Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Regeneron Pharmaceuticals Major Business
Table 47. Regeneron Pharmaceuticals Covid-19 Treatment Product and Solutions
Table 48. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Regeneron Pharmaceuticals Recent Developments and Future Plans
Table 50. Ascletis Pharma Company Information, Head Office, and Major Competitors
Table 51. Ascletis Pharma Major Business
Table 52. Ascletis Pharma Covid-19 Treatment Product and Solutions
Table 53. Ascletis Pharma Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Ascletis Pharma Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Covid-19 Treatment Product and Solutions
Table 58. GlaxoSmithKline Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 61. Gilead Sciences Major Business
Table 62. Gilead Sciences Covid-19 Treatment Product and Solutions
Table 63. Gilead Sciences Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Gilead Sciences Recent Developments and Future Plans
Table 65. Pharmstandard Company Information, Head Office, and Major Competitors
Table 66. Pharmstandard Major Business
Table 67. Pharmstandard Covid-19 Treatment Product and Solutions
Table 68. Pharmstandard Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Pharmstandard Recent Developments and Future Plans
Table 70. Fujifilm Holdings Company Information, Head Office, and Major Competitors
Table 71. Fujifilm Holdings Major Business
Table 72. Fujifilm Holdings Covid-19 Treatment Product and Solutions
Table 73. Fujifilm Holdings Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Fujifilm Holdings Recent Developments and Future Plans
Table 75. Zhejiang Hisun Pharmaceutical Co. Ltd Company Information, Head Office, and Major Competitors
Table 76. Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
Table 77. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product and Solutions
Table 78. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
Table 80. Roche Company Information, Head Office, and Major Competitors
Table 81. Roche Major Business
Table 82. Roche Covid-19 Treatment Product and Solutions
Table 83. Roche Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Roche Recent Developments and Future Plans
Table 85. Sanofi Company Information, Head Office, and Major Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi Covid-19 Treatment Product and Solutions
Table 88. Sanofi Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sanofi Recent Developments and Future Plans
Table 90. Pfizer Company Information, Head Office, and Major Competitors
Table 91. Pfizer Major Business
Table 92. Pfizer Covid-19 Treatment Product and Solutions
Table 93. Pfizer Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Pfizer Recent Developments and Future Plans
Table 95. Eli Lilly Company Information, Head Office, and Major Competitors
Table 96. Eli Lilly Major Business
Table 97. Eli Lilly Covid-19 Treatment Product and Solutions
Table 98. Eli Lilly Covid-19 Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Eli Lilly Recent Developments and Future Plans
Table 100. Global Covid-19 Treatment Revenue (USD Million) by Players (2019-2024)
Table 101. Global Covid-19 Treatment Revenue Share by Players (2019-2024)
Table 102. Breakdown of Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Covid-19 Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Covid-19 Treatment Players
Table 105. Covid-19 Treatment Market: Company Product Type Footprint
Table 106. Covid-19 Treatment Market: Company Product Application Footprint
Table 107. Covid-19 Treatment New Market Entrants and Barriers to Market Entry
Table 108. Covid-19 Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Covid-19 Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Covid-19 Treatment Consumption Value Share by Type (2019-2024)
Table 111. Global Covid-19 Treatment Consumption Value Forecast by Type (2025-2030)
Table 112. Global Covid-19 Treatment Consumption Value by End User (2019-2024)
Table 113. Global Covid-19 Treatment Consumption Value Forecast by End User (2025-2030)
Table 114. North America Covid-19 Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Covid-19 Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Covid-19 Treatment Consumption Value by End User (2019-2024) & (USD Million)
Table 117. North America Covid-19 Treatment Consumption Value by End User (2025-2030) & (USD Million)
Table 118. North America Covid-19 Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Covid-19 Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Covid-19 Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Covid-19 Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Covid-19 Treatment Consumption Value by End User (2019-2024) & (USD Million)
Table 123. Europe Covid-19 Treatment Consumption Value by End User (2025-2030) & (USD Million)
Table 124. Europe Covid-19 Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Covid-19 Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Covid-19 Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2019-2024) & (USD Million)
Table 129. Asia-Pacific Covid-19 Treatment Consumption Value by End User (2025-2030) & (USD Million)
Table 130. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Covid-19 Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Covid-19 Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Covid-19 Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Covid-19 Treatment Consumption Value by End User (2019-2024) & (USD Million)
Table 135. South America Covid-19 Treatment Consumption Value by End User (2025-2030) & (USD Million)
Table 136. South America Covid-19 Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Covid-19 Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Covid-19 Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2019-2024) & (USD Million)
Table 141. Middle East & Africa Covid-19 Treatment Consumption Value by End User (2025-2030) & (USD Million)
Table 142. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Covid-19 Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Covid-19 Treatment Raw Material
Table 145. Key Suppliers of Covid-19 Treatment Raw Materials
List of Figures
Figure 1. Covid-19 Treatment Picture
Figure 2. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Covid-19 Treatment Consumption Value Market Share by Type in 2023
Figure 4. Life Support
Figure 5. Antiviral Medicine
Figure 6. Antibody Treatments
Figure 7. Others
Figure 8. Global Covid-19 Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Covid-19 Treatment Consumption Value Market Share by End User in 2023
Figure 10. Children Picture
Figure 11. Adult Picture
Figure 12. Global Covid-19 Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Covid-19 Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Covid-19 Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Covid-19 Treatment Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Covid-19 Treatment Consumption Value Market Share by Region in 2023
Figure 17. North America Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Covid-19 Treatment Revenue Share by Players in 2023
Figure 23. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Covid-19 Treatment Market Share in 2023
Figure 25. Global Top 6 Players Covid-19 Treatment Market Share in 2023
Figure 26. Global Covid-19 Treatment Consumption Value Share by Type (2019-2024)
Figure 27. Global Covid-19 Treatment Market Share Forecast by Type (2025-2030)
Figure 28. Global Covid-19 Treatment Consumption Value Share by End User (2019-2024)
Figure 29. Global Covid-19 Treatment Market Share Forecast by End User (2025-2030)
Figure 30. North America Covid-19 Treatment Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Covid-19 Treatment Consumption Value Market Share by End User (2019-2030)
Figure 32. North America Covid-19 Treatment Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Covid-19 Treatment Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Covid-19 Treatment Consumption Value Market Share by End User (2019-2030)
Figure 38. Europe Covid-19 Treatment Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 40. France Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by End User (2019-2030)
Figure 46. Asia-Pacific Covid-19 Treatment Consumption Value Market Share by Region (2019-2030)
Figure 47. China Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 50. India Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Covid-19 Treatment Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Covid-19 Treatment Consumption Value Market Share by End User (2019-2030)
Figure 55. South America Covid-19 Treatment Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by End User (2019-2030)
Figure 60. Middle East and Africa Covid-19 Treatment Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Covid-19 Treatment Consumption Value (2019-2030) & (USD Million)
Figure 64. Covid-19 Treatment Market Drivers
Figure 65. Covid-19 Treatment Market Restraints
Figure 66. Covid-19 Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Covid-19 Treatment in 2023
Figure 69. Manufacturing Process Analysis of Covid-19 Treatment
Figure 70. Covid-19 Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Cadila Healthcare Johnson & Johnson ImmunoPrecise Novartis AstraZeneca Cipla AbbVie Bayer Regeneron Pharmaceuticals Ascletis Pharma GlaxoSmithKline Gilead Sciences Pharmstandard Fujifilm Holdings Zhejiang Hisun Pharmaceutical Co. Ltd Roche Sanofi Pfizer Eli Lilly
18 Mar 2023
Medical Care
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
